164 related articles for article (PubMed ID: 32460865)
1. Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 "QUAD shot" regimen for incurable head and neck cancer.
Toya R; Saito T; Yamaguchi K; Matsuyama T; Watakabe T; Matsumoto T; Yoshida R; Hirosue A; Murakami D; Orita Y; Nakayama H; Oya N
Radiat Oncol; 2020 May; 15(1):123. PubMed ID: 32460865
[TBL] [Abstract][Full Text] [Related]
2. Radiation Therapy Oncology Group 8502 "QUAD shot" regimen using volumetric modulated arc therapy for incurable head and neck cancer.
Toya R; Fukugawa Y; Saito T; Matsuyama T; Yoshida R; Murakami D; Orita Y; Nakayama H; Oya N
Oral Oncol; 2024 Apr; 151():106752. PubMed ID: 38518555
[TBL] [Abstract][Full Text] [Related]
3. Cyclical hypofractionated radiotherapy also known as "QUAD Shot" alone using intensity-modulated radiotherapy for squamous cell carcinoma of the parotid gland in an 85-year-old patient with multiple comorbidities.
Kil WJ; Camphausen K
Head Neck; 2017 Apr; 39(4):E55-E60. PubMed ID: 28170130
[TBL] [Abstract][Full Text] [Related]
4. Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers.
Lok BH; Jiang G; Gutiontov S; Lanning RM; Sridhara S; Sherman EJ; Tsai CJ; McBride SM; Riaz N; Lee NY
Oral Oncol; 2015 Oct; 51(10):957-62. PubMed ID: 26282714
[TBL] [Abstract][Full Text] [Related]
5. The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer.
Corry J; Peters LJ; Costa ID; Milner AD; Fawns H; Rischin D; Porceddu S
Radiother Oncol; 2005 Nov; 77(2):137-42. PubMed ID: 16260054
[TBL] [Abstract][Full Text] [Related]
6. Cyclical hypofractionated radiotherapy technique for palliative treatment of locally advanced head and neck cancer: institutional experience and review of palliative regimens.
Finnegan TS; Bhatt NH; Shaughnessy JN; Perez C; Redman R; Silverman C; Bumpous J; Potts K; Dunlap NE
J Community Support Oncol; 2016 Jan; 14(1):29-36. PubMed ID: 26870840
[TBL] [Abstract][Full Text] [Related]
7. Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases.
Benhmida S; Sun R; Gherga E; Hammoud Y; Rouvier J; Mauvais O; Bockel S; Louvrier A; Lebbad A; Bontemps P; Ortholan C; Bourhis J; Lestrade L; Sun XS
Cancer Radiother; 2020 Dec; 24(8):812-819. PubMed ID: 33144061
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated Palliative Radiotherapy with Concurrent Radiosensitizing Chemotherapy for Advanced Head and Neck Cancer Using the "QUAD-SHOT Regimen".
Gamez ME; Agarwal M; Hu KS; Lukens JN; Harrison LB
Anticancer Res; 2017 Feb; 37(2):685-691. PubMed ID: 28179317
[TBL] [Abstract][Full Text] [Related]
9. QUAD SHOT - an effective hypofractionated palliative radiotherapy in patients with non-melanoma skin cancer. A single-institution experience.
Graczyk Ł; Bibik R; Woźniak A; Jesień-Lewandowicz E; Ciupis J; Szyburski M; Bajer J; Chałubińska-Fendler J; Fijuth J; Jońska-Gmyrek JG
Contemp Oncol (Pozn); 2023; 27(2):80-89. PubMed ID: 37794986
[TBL] [Abstract][Full Text] [Related]
10. Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy for Head and Neck Cancer.
Mayo ZS; Ilori EO; Matia B; Smile TD; Fleming CW; Reddy CA; Scharpf J; Lamarre ED; Prendes BL; Ku J; Burkey BB; Joshi NP; Woody NM; Koyfman SA; Campbell SR
Anticancer Res; 2022 Apr; 42(4):1845-1849. PubMed ID: 35347002
[TBL] [Abstract][Full Text] [Related]
11. Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers.
Fan D; Kang JJ; Fan M; Wang H; Lee A; Yu Y; Chen L; Jillian Tsai C; McBride SM; Riaz N; Gelblum DY; Neal BP; Fetten J; Dunn LA; Michel LS; Boyle JO; Cohen MA; Roman BR; Ganly I; Singh B; Wong RJ; Sherman EJ; Lee NY
Oral Oncol; 2020 May; 104():104641. PubMed ID: 32182548
[TBL] [Abstract][Full Text] [Related]
12. QUAD shot: an effective cyclical hypofractionated palliative radiotherapy for salivary gland carcinoma.
Toya R; Saito T; Matsuyama T; Watakabe T; Yamaguchi K; Murakami D; Honda Y; Mizutari S; Orita Y; Oya N
BJR Case Rep; 2020 Dec; 6(4):20190132. PubMed ID: 33299577
[TBL] [Abstract][Full Text] [Related]
13. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
[TBL] [Abstract][Full Text] [Related]
14. Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme.
Chen AM; Vaughan A; Narayan S; Vijayakumar S
Head Neck; 2008 Dec; 30(12):1586-91. PubMed ID: 18798313
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy of prostate and head-and-neck tumour: An optimal treatment planning comparison for intensity modulated radiotherapy and volumetric modulated arctherapy techniques.
Murtaza G
J Pak Med Assoc; 2024 Jan; 74(1):16-20. PubMed ID: 38219158
[TBL] [Abstract][Full Text] [Related]
16. Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy.
Franzese C; Fogliata A; Clerici E; Franceschini D; Villa E; D'Agostino G; Navarria P; Mancosu P; Tomatis S; Cozzi L; Scorsetti M
Radiat Oncol; 2015 Nov; 10():224. PubMed ID: 26545871
[TBL] [Abstract][Full Text] [Related]
17. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
18. Conventional Fractionation versus Quad Shot in Advanced Head-and-Neck Cancers: A Randomized Controlled Trial.
Choudhary A; Gupta A
Indian J Palliat Care; 2019; 25(4):527-534. PubMed ID: 31673207
[TBL] [Abstract][Full Text] [Related]
19. Importance of dose in palliative treatment for incurable head and neck cancer with radiotherapy.
García-Anaya MJ; Ordoñez R; Toledo MD; Correa RC; Otero A; Román A; García-Ríos I; Medina JA; Gómez-Millán J
Head Neck; 2021 Mar; 43(3):798-804. PubMed ID: 33325113
[TBL] [Abstract][Full Text] [Related]
20. Is there a dosimetric advantage of volumetric modulated arc therapy over intensity modulated radiotherapy in head and neck cancer?
Buciuman N; Marcu LG
Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5311-5321. PubMed ID: 35598230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
